This study identifies an intestinal marker, glutathione peroxidase 4 (GPX4), that predicts Crohn’s disease recurrence after surgery and demonstrates it could be targeted to prevent or treat Crohn’s disease.
Gastroenterology (AGA) published a clinical update in Research Highlights on 16 Mar 2026.
The item focuses on Identification of a Druggable Target That Predicts Postoperative Crohn’s Disease Recurrence.
Review the original article for the full source wording and details.